Delivery of gamma-imaging agents by liposomes

Advanced Drug Delivery Reviews

Volumn 37, Issue 1-3, 1999, Pages 13-32

  Phillips, William T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Background substration; Blood pool; Gallium 67; Indium 111; Infection; Inflammation; Liposomes; Lymphoscintigraphy; Scintigraphy; Targeting; Technetium 99m; Tumor

Indexed keywords

AGENTS; CELL MEMBRANES; DIAGNOSTIC RADIOGRAPHY; ENCAPSULATION; GALLIUM; GAMMA RADIOGRAPHY; INDIUM; LABELING; LIPIDS; MEDICAL IMAGING; TECHNETIUM;

BACKGROUND SUBSTRATION; BLOOD POOL; GAMMA IMAGING AGENTS; INFECTION; INFLAMMATION; LIPOSOMES; LYMPHOSCINTIGRAPHY; SCINTIGRAPHY; TARGETING; TUMOR;

CONTROLLED DRUG DELIVERY;

CANCER ANTIBODY; GALLIUM 67; GLUTATHIONE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LIPID; LIPOSOME; LIPOSOME IN 111; LIPOSOME TC 99M; PENTETIC ACID; RADIOISOTOPE; RECEPTOR; TECHNETIUM 99M; WATER;

BLOOD POOL SCINTISCANNING; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; ENCAPSULATION; GAMMA IRRADIATION; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; IMAGING; INFECTION; INFLAMMATION; LIPID BILAYER; LYMPHOSCINTIGRAPHY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; TECHNIQUE; TUMOR;

EID: 0344958781     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00108-2     Document Type: Review

References (98)

1. F.J. Szoka, D. Papahadjopoulos, Comparative properties and methods of preparation of lipid vesicles (liposomes), Annu. Rev. Biophys. Bioeng. 9 (1980) 467-508.
2. D. Lasic, Liposomes, Sci. Med. 3 (1996) 34-43.
3. G. Gregoriadis, Overview of liposomes, J. Antimicrob Chemother. 28(Suppl. B) (1991) 39-48.
4. G. Gregoriadis, Targeting of drugs: implications in medicine, Horiz. Biochem. Biophys. 9 (1989) 1-31.
5. K.J. Hwang, Liposome pharmocokinetics, in: M.J. Ostro (Ed.), Liposomes from Biophysics to Therapeutics, Marcel Dekker, New York, 1987, pp. 109-154.
6. D. Papahadjopoulous, N. Miller, Phospholipid model membranes: structural characteristics of hydrated liquid crystals, Biochim. Biophys. Acta 135 (1967) 624-638.
7. L. Saunders, J. Perrin, D.B. Gammack, Ultrasonic irradiation of some phopholipid sol, J. Pharm. Pharmacol. 14 (1962) 567-572.
8. V.J. Caride, Technical and biological considerations on the use of radiolabeled liposomes for diagnostic imaging, Nucl. Med. Biol. 17 (1990) 35-39.
9. D. Lasic, Liposomes, Am. Scientist 80 (1992) 20-31.
10. S.E. Seltzer, The role of liposomes in diagnostic imaging, Radiology 171 (1989) 19-21.
11. G. Dutton, Liposomes edge toward US market after overcoming development hurdles, Genetic Eng. News 13(3) (1993) 6.
12. M.J. Ostro, Liposomes - from the bench to the marketplace: doxrubicin liposomes as an example, in: G. Lopez-Berestein, I.J. Fidler (Eds.), Liposomes in the Therapy of Infectious Diseases and Cancer, Alan R. Liss, New York, 1989, pp. 155-163.
13. W.T. Phillips, B. Goins, Targeted delivery of imaging agents by liposomes, in: V.P. Torchilin (Ed.), Handbook of Targeted Delivery of Imaging Agents, CRC Press, Boca Raton, FL, 1995, pp. 149-173.
14. D.J. Hnatowich, B. Friedman, B. Clancy, M. Novak, Labeling of preformed liposomes with Ga-67 and Tc-99m by chelation, J. Nucl. Med. 22 (1981) 810-814.
15. I.K. Adzaml, S.E. Seltzer, M. Slifkin, M. Blau, D.F. Adams, Production and characterization of improved liposomes containing radiographic contrast media, Invest. Radiol. 25 (1990) 1217.
16. I.R. McDougall, J.K. Dunnick, M.G. McNamee, J.P. Kriss, Distribution and fate of synthetic lipid vesicles in the mouse: a combined radionuclide and spin label study, Proc. Natl. Acad. Sci. USA 71 (1974) 3487-3491.
17. I.R. McDougall, J.K. Dunnick, M.L. Goris, J.P. Kriss, In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration, J. Nucl. Med. 16 (1975) 488-492.
18. 99mTc-DTPA] in mice, J. Nucl. Med. 17 (1976) 1067-1072.
19. J.K. Dunnick, I.R. McDougall, S. Aragon, M.L. Goris, J.P. Kriss, Vesicle interactions with polyamino acids and antibody: in vitro and in vivo studies, J. Nucl. Med. 16 (1975) 484-487.
20. J. Damen, J. Regts, G. Scherphof, Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins, Biochim. Biophys. Acta 665 (1981) 538.
21. M.C. Woodle, 67Gallium-labeled lipsomes with prolonged circulation: preparation and potential as nuclear imaging agents, Nucl. Med. Biol. 20 (1993) 149-155.
22. I. Ogihara-Umeda, S. Kojima, Increased delivery of gallium-67 to tumors using serum-stable liposomes, J. Nucl. Med. 29 (1988) 516-523.
23. A. Gabizon, J. Huberty, R.M. Straubinger, D.C. Price, D. Papahadjopoulos, An improved method for in vivo tracing and imaging of liposomes using a gallium 67-deferoxamine complex, J. Liposome Res. 1 (1988) 123-135.
24. P.L. Beaumier, K.J. Hwang, An efficient method for loading indium-111 into liposomes using acetylacetone, J. Nucl. Med. 23 (1982) 810-815.
25. K.J. Hwang, J.E. Merriam, P.L. Beaumier, K.S. Luk, Encapsulation, with high efficiency, of radioactive metal ions in liposomes, Biochim. Biophys. Acta 716 (1982) 101-109.
26. A. Gabizon, D.C. Price, J. Huberty, R.S. Bresalier, D. Papahadjopoulos, Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies, Cancer Res. 50 (1990) 6371-6378.
27. M.R. Mauk, R.C. Gamble, Preparation of lipid vesicles containing high levels of entrapped radioactive cations, Anal. Biochem. 94 (1979) 302-307.
28. V.J. Caride, Liposome for diagnostic imaging, in: R.P. Spencer (Ed.), Radiopharmaceuticals Structure-Activity Relationships, Grune and Stratton, New York, 1981, pp. 477-503.
29. L.G. Espinola, J. Beaucaire, A. Gottschalk, V.J. Caride, Radiolabeled liposomes as metabolic and scanning tracers in mice. II. In-111 oxine compared with Tc-99m DTPA, entrapped in multilamellar lipid vesicles, J. Nucl. Med. 20 (1979) 434-440.
30. V.J. Caride, B.L. Zaret, Liposome accumulation in regions of experimental myocardial infarction, Science 198 (1977) 735-738.
31. G.M. Barratt, N.S. Tuzel, B.E. Ryman, The labeling of liposomal membranes with radioactive technetium, in: G. Gregoriadis (Ed.), Liposome Technology, CRC Press, Boca Raton, FL, 1984, pp. 93-106.
32. 99mTc] technetium-labelled liposomes in normal and tumour-bearing rats, Biochem. Soc. Trans. 5 (1977) 290-291.
33. V.J. Richardson, K. Jeyasingh, R.F. Jewkes, B.E. Ryman, M.H.N. Tattersall, Possible tumor localization of Tc-99m-labeled liposomes: effects of lipid composition, charge and liposome size, J. Nucl. Med. 19 (1978) 1049-1054.
34. 99mTc) radiolabelled liposomes, Ann. Rheumatic Diseases 6 (1989) 105-113.
35. R. Goto, H. Kubo, S. Okada, Liposomes prepared from synthetic amphiphiles. I. Their technetium labelling and stability, Chem. Pharm. Bull. 37 (1989) 1351-1354.
36. 99mTc-labeling of lipid vesicles containing the lipophilic chelator PE-DTPA: effect of tin-to-chelate ratio, chelate content and surgace polymer on labeling efficiency and biodistribution behavior, Nucl. Med. Biol. 21 (1994) 89-96.
37. 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoylphosphatidylethanolamine-DTTA, Nucl. Med. Biol. 19 (1992) 831-840.
38. W.T. Phillips, A.S. Rudolph, B. Goins, J.H. Timmons, R. Klipper, R. Blumhardt, A simple method for producing a technetium-99m-labeled liposome which is stable in vivo, Nucl. Med. Biol. 19 (1992) 539-547.
39. R.D. Neirinckx, J.F. Burke, R.C. Harrison, A.M. Foster, A.R. Andersen, N.A. Lassen, The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione, J. Cereb. Blood Flow Metab. 8 (1988) S4-S12.
40. O.C. Boerman, W.J.G. Oyen, L.v. Bloois, E.B. Koenders, J.W.M.v.d. Meer, F.H.M. Corstens, Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time, J. Nucl. Med. 38 (1997) 489-493.
41. O.C. Boerman, W.J.G. Oyen, G. Storm, M.L. Corvo, L.v. Boois, J.W.M.v.d. Meer, F.H.M. Corstens, Technetium-99m labelled liposomes to image experimental arthritis, Ann. Rheum. Dis. 56 (1997) 369-373.
42. W.J.G. Oyen, O.C. Boerman, G. Storm, L.V. Bloois, E.B. Koenders, D.J.A. Crommelin, J.W.M.V.D. Meer, F.H.M. Corstens, Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy? Nucl. Med. Commun. 17 (1996) 742-748.
43. C. Tilcock, M. Yap, M. Szucs, D. Utkhede, PEG-coated lipid vesicles with encapsulated technetium-99m as blood pool agents for nuclear medicine, Nucl. Med. Biol. 21 (1994) 165-170.
44. I. Ogihara-Umeda, T. Sasaki, S. Kojima, H. Nishigori, Optimal radiolabeled liposomes for tumor imaging, J. Nucl. Med. 37 (1996) 326-332.
45. A.S. Rudolph, R.W. Klipper, B. Goins, W.T. Phillips, In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit, Proc. Natl. Acad. Sci. USA 88 (1991) 10976-10980.
46. V.D. Awasthi, B. Goins, R. Klipper, W.T. Phillips, Dual radiolabeled liposomes: biodistribution studies and localization of focal sites of infection in rats, Nucl. Med. Biol. 25 (1998) 155-160.
47. B. Goins, R. Klipper, A.S. Rudolph, W.T. Phillips, Use of technetium-99m-liposomes in tumor imaging, J. Nucl. Med. 35 (1994) 1491-1498.
48. T.M. Allen, Stealth Liposomes: Avoiding Reticuloendothelial Uptake Liposomes in the Therapy of Infectious Diseases and Cancer, Alan R. Liss, New York, 1989, pp. 405-415.
49. J. Senior, C. Delgado, D. Fisher, C. Tilcock, G. Gregoriadis, Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance form the circulation: studies with poly(ethylene glycol)-coated vesicles, Biochim. Biophys. Acta 1062 (1991) 77-82.
50. A. Mori, A.L. Klibanov, V.P. Torchilin, L. Huang, Influence of the steric barrier activity of amphipathic poly-(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo, FEBS 284 (1991) 263-266.
51. V.D. Awasthi, B. Goins, R. Klipper, R. Loredo, D. Korvick, W.T. Phillips, Imaging experimental osteomyelitis using radiolabeled liposomes. J. Nucl. Med., in press.
52. I. Ogihara-Umeda, T. Sasaki, H. Nishigori, Active removal of radioactivity in the blood circulation using biotin-bearing lipsomes and avidin for rapid tumour imaging, Eur. J. Nucl. Med. 20 (1993) 170-172.
53. B. Goins, V.D. Awasthi, R. Klipper, W.T. Phillips, Use of a technetium-99m (Tc-99m)-labeled biotin-liposome/avidin system in a rabbit colitis model to improve early image detection, J. Nucl. Med. 5(Suppl.) (1998) 125P-126P.
54. P. Laverman, W.J.G. Oyen, G. Storm, E.T.M. Dams, N. Mullah, S. Zalipsky, F.H.M. Corstens, O.C. Boerman, Improved imaging of infection by avidin induced clearance of Tc-99m-biotin-PEG-liposomes, J. Nucl. Med. 5(Suppl.) (1998) 267P.
55. B. Goins, W.T. Phillips, R. Klipper, Repeat injection studies of technetium-99m-labeled PEG-liposomes in the same animal, J. Liposome Res., in press.
56. E.T.M. Dams, W.J.G. Oyen, O.C. Boerman, P. Laverman, G. Storm, J.W.M. van der Meer, F.H.M. Corstens, Effect of multiple injections on pharmacokinetics and biodistribution of sterically stabilized liposomes, J. Nucl. Med. 5(Suppl.) (1998) 242P.
57. C.A. Presant, G. Ksionski, R. Crossley, 111In-labeled liposomes for tumor imaging: clinical results of the international liposome imaging study, J. Liposome Res. 1 (1990) 431.
58. A. Gabizon, R. Catane, B. Uziely, B. Kaufman, T. Safra, R. Cohen, F. Martin, A. Huang, Y. Barenholz, Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene glycol coated liposomes, Cancer Res. 54 (1994) 987-992.
59. T.M. Allen, C. Hansen, F. Martin, C. Redemann, A. YauYoung, Liposomes containing synthetic lipid derivative of poly(ethylene) show prolonged circulation half-lives in vivo, Biochim. Biophys. Acta 1066 (1991) 29-36.
60. D. Papahadjopoulos, A.A. Gabizon, Sterically stabilized (Stealth) liposomes: pharmacological properties and drug carrying potential in cancer, in: J.R. Philippot, F. Schuber (Eds.), Liposomes as Tools in Basic Research and Industry, CRC Press, Boca Raton, F.L., 1995, pp. 177-188.
61. V.D. Awasthi, B. Goins, R. Klipper, W.T. Phillips, Dual radiolabeled liposomes: biodistribution studies and localization of focal sites of infection in rats, Nucl. Med. Biol. 25 (1998) 155-160.
62. O.C. Boerman, W.J.G. Oyen, L. van Bloois, E.B. Koenders, J.W.M. van der Meer, F.H.M. Corstens, G. Storm, Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time, J. Nucl. Med. 38 (1997) 489-493.
63. O.C. Boerman, G. Storm, W.J.G. Oyen, L. van Bloois, J.W.M. van der Meer, R.A.M.J. Claessens, D.J.A. Crommelin, F.H.M. Corstens, Sterically stabilized liposomes labeled with indium-111 to image focal infection, J. Nucl. Med. 36 (1995) 1639-1644.
64. O.C. Boerman, W.J.G. Oyen, E. Dams, G. Storm, J.W.M. van der Meer, F.H.M. Corstens, Optimization of labeled Stealth liposomes to image infection and inflammation, J. Nucl. Med. 38 (1997) 268P.
65. O.C. Boerman, W.J.G. Oyen, L. van Bloois, E.B. Koenders, J.W.M. van der Meer, F.H.M. Corstens, G. Storm, Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time, J. Nucl. Med. 38 (1997) 489-493.
66. B. Goins, R. Klipper, R.O. Cliff, R. Blumhardt, W.T. Phillips, Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection, J. Nucl. Med. 34 (1993) 2160-2168.
67. B. Goins, S.K. Aggarwal, R. Klipper, V.D. Awasthi, R.A. Lawrence, S.G. Jenkinson, W.T. Phillips, Technetium-99m-labeled liposomes versus gallium-67 citrate for detection of hyperoxia-induced lung inflammation in rats, J. Nucl. Med. 38 (1997) 185P.
68. W.J.G. Oyen, O.C. Boerman, G. Storm, L. van Bloois, E.B. Koenders, R.A.M.J. Claessens, R.M. Perenboom, D.A.J. Crommelin, J.W.M. van der Meer, F.H.M. Corstens, Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes, J. Nucl. Med. 37 (1996) 1392-1397.
69. W.J.G. Oyen, O.C. Boerman, G. Storm, L. van Bloois, E.B. Koenders, D.J.A. Crommelin, J.W.M. van der Meer, F.H.M. Corstens, Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy? Nucl. Med. Commun. 17 (1996) 742-748.
70. W.J.G. Oyen, O.C. Boerman, E.T.M. Dams, G. Storm, L. van Bloois, E.B. Koenders, D.J. Crommelin, J.W.M. van der Meer, F.H.M. Corstens, Evaluation of experimental colitis with In-Ill labeled liposomes, leukocytes and IgG, Eur. J. Nucl. Med. 23 (1996) 1062.
71. W.J.G. Oyen, O.C. Boerman, G. Storm, L. van Bloois, E.B. Koenders, R.A.M.J. Claessens, R.M. Perenboom, D.J.A. Crommelin, J.W.M. van der Meer, F.H.M. Corstens, Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes, J. Nucl. Med. 37 (1996) 1392-1396.
72. 99mTc-technetium-labelled liposomes, J. Med. Microbiol. 14 (1981) 213-217.
73. W.J.G. Oyen, O.C. Boerman, C.J.v.d. Laken, R.A.M.J. Claessens, J.W.M.v.d. Meer, R.H.M. Corstens, The uptake mechanisms of inflammation- and infection-localizing agents, Eur. J. Nucl. Med. 23 (1996) 459-465.
74. W.G. Love, N. Amos, I.W. Kellaway, B.D. Williams, Specific accumulation of technetium-99m radiolabelled, negative liposomes in the inflamed paws of rats with adjuvant induced arthritis: effect of liposome size, Ann. Rheumatic Diseases 48 (1989) 143-148.
75. I. Ogihara, S.J.M. Kojima, Differential uptake of gallium-67-labeled liposomes between tumors and inflammatory lesions in rats, J. Nucl. Med. 27 (1986) 1300-1307.
76. M.M. O'Sullivan, N. Powell, A.P. French, K.E. French, K.E. Williams, I.R. Morgan, B.D. Williams, Inflammatory joint disease: a comparison of liposome scanning, bone scanning and radiography, Ann. Rheumatic Diseases 47 (1988) 485-491.
77. B. Goins, W.T. Phillips, R. Klipper, Blood-pool imaging using technetium-99m-labeled liposomes, J. Nucl. Med. 37 (1996) 1374-1379.
78. H.M. Patel, K.M. Boodle, R. Vaughan-Jones, Assessment of the potential uses of liposomes for lymphoscintigraphy and lymphatic drug delivery. Failure of 99m-technetium to represent intact liposomes in lymph nodes, Biochim. Biophys. Acta 801 (1984) 76-86.
79. M. Velinova, N. Read, C. Kirby, G. Gregoriadis, Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats, Biochim. Biophys. Acta 1299 (1996) 207-215.
80. C. Oussoren, G. Storm, Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol), Pharmacol. Res. 14 (1997) 1479-1484.
81. C. Oussoren, G. Storm, Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol), Pharm. Res. 14 (1997) 1479-1484.
82. C. Oussoren, J. Zuidema, D.J.A. Cormmelin, G. Storm, Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose, Biochim. Biophys. Acta 1328 (1997) 261-272.
83. S.M. Moghimi, A.R. Rajabi-Siahboomi, Advanced colloid-based systems for efficient delivery of drugs and diagnostic agents to the lymphatic tissues, Prog. Biophys. Mol. Biol. 65 (1996) 221-249.
84. T.M. Allen, C.B. Hansen, L.S.S. Guo, Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection, Biochim. Biophys. Acta 1150 (1993) 9-16.
85. T.N. Palmer, V.J. Caride, L.A. Fernandez, J. Twickler, Liposome accumulation in ischaemic intestine following experimental mesenteric occlusion, Biosci. Reports 1 (1981) 337-344.
86. V.P. Torchilin, Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents, Immunomethods 4 (1994) 244-258.
87. V.P. Torchilin, A.L. Klibanov, L. Huang, S. O'Donnell, N.D. Nossiff, B.A. Khaw, Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium, FASEB J. 6 (1992) 2716-2719.
88. K. Maruyama, T. Takizawa, T. Yuda, S.J. Kennel, L. Huang, M. Iwatsuru, Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies, Biochim. Biophys. Acta 1234 (1995) 74-80.
89. T.M. Allen, E. Brandeis, C.B. Hansen, G.Y. Kao, S. Zalipsky, A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells, Biochim. Biophys. Acta 1237 (1995) 99-108.
90. S. Zalipsky, B. Puntambekar, P. Boulikas, C.M. Engbers, M.C. Woodle, Peptide attachment to extremities of liposomal surface grafted PEG chains: preparation of the long-circulating form of laminin pentapeptide, YIGSR, Bioconj. Chem. 6 (1995) 705-708.
91. J.A. Harding, C.M. Engbers, M.S. Newman, N.I. Glodstein, S. Zalipsky, Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes, Biochim. Biophys. Acta 1327 (1997) 181-192.
92. S.F. Farr, I.W. Kellaway, D.R. Parry-Jones, S.G. Woolfrey, 99m-Technetium as a marker of liposomal deposition and clearance in the human lung, Int. J. Pharm. 26 (1985) 303-316.
93. A. Gabizon, J. Huberty, R.M. Straubinger, D.C. Price, D. Papahadjpulos, An improved method for in vivo tracing and imaging of liposomes using a gallium-67-desferoxamine complex, J. Liposome Res. 1 (1989) 123-135.
94. B. Goins, R. Klipper, J. Sanders, R.O. Cliff, A.S. Rudolph, W.T. Phillips, Physiological responses, organ distribution, and circulation kinetics in anesthetized rats after hypovolemic exchange transfusion with technetium-99m-labeled liposome-encapsulated hemoglobin, SHOCK 4 (1995) 121-130.
95. W.T. Phillips, A.S. Rudolph, B. Goins, R. Klipper, Biodistribution studies of liposome encapsulated hemoglobin (LEH) studied with a newly developed 99m-technetium liposome label, Biomat. Art. Cells Immob. Biotech. 20 (1992) 757-760.
96. A.S. Rudolph, R.W. Klipper, B. Goins, W.T. Phillips, In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome encapsulated hemoglobin in an anesthetized rabbit, Proc. Natl. Acad. Sci. USA 88 (1991) 10976-10980.
97. V.P. Torchilin, Targeting of thrombolytic agents: current state of knowledge and perspectives, Ann. NY Acad. Sci. 667 (1992) 404-416.
98. S.M. Moghimi, A.R. Rajabi-Siahboomi, Advanced colloid-based systems for efficient delivery of drugs and diagnostic agenst to the lymphatic tissues, Prog. Biophys. Mol. Biol. 65 (1996) 221-249.